Mercaptopurine monohydrate - paediatric investigation plan

Mercaptopurine monohydrate

Key facts

• Active substance:
  Mercaptopurine monohydrate
• Therapeutic area:
  Oncology
• Decision number:
  P/73/2009
• PIP number:
  Mercaptopurine monohydrate
• Pharmaceutical form(s):
  Oral suspension
• Condition(s) / indication(s):
  Treatment of acute lymphoblastic leukaemia
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  20/04/2009
• Compliance check done:
  No

Decision

P/73/2009: European Medicines Agency decision of 20 April 2009 on the agreement of a Paediatric Investigation Plan for mercaptopurine monohydrate (EMEA-000350-PIP01-08) in accordance with Regulation (EC) No 1901/2006 of ...

Adopted Reference Number: EMEA/233188/2009